Regional Health Properties(DE:2YZ)
€2.520.00 (0.00%)
DE:2YZ
Regional Health Properties financials statements
€2.52
At close:0.00 (0.00%)
Regional Health Properties (2YZ) Ratios
0 Followers
Regional Health Properties Ratios
DE:2YZ's free cash flow for Q2 2026 was $889.00K. For the 2026 fiscal year, DE:2YZ's free cash flow was decreased by $-498.00K and operating cash flow was $1.39M. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Mar 25 | Mar 24 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.91 | 1.16 | 1.42 | 1.84 | 2.55 |
| Quick Ratio | 0.91 | 1.16 | 1.42 | 1.84 | 2.55 |
| Cash Ratio | 0.00 | 0.03 | 0.07 | 0.11 | 0.83 |
| Solvency Ratio | 0.09 | -0.02 | -0.03 | -0.07 | 0.01 |
| Operating Cash Flow Ratio | -0.00 | 0.11 | 0.26 | -0.47 | 0.59 |
| Short-Term Operating Cash Flow Coverage | -0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ -42.27M | $ -43.32M | $ -41.87M | $ -50.66M | $ -74.29M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.62 | 0.73 | 0.73 | 0.81 | 0.80 |
| Debt-to-Equity Ratio | 8.43 | -15.06 | 246.93 | 14.91 | 8.17 |
| Debt-to-Capital Ratio | 0.89 | 1.07 | 1.00 | 0.94 | 0.89 |
| Long-Term Debt-to-Capital Ratio | 0.87 | 1.08 | 1.00 | 0.93 | 0.84 |
| Financial Leverage Ratio | 13.60 | -20.71 | 336.11 | 18.46 | 10.17 |
| Debt Service Coverage Ratio | 1.00 | 0.82 | 0.41 | -0.76 | 1.53 |
| Interest Coverage Ratio | -0.07 | 0.06 | -0.30 | -2.70 | 0.95 |
| Debt to Market Cap | 11183.16 | 14.31 | 11.22 | 8.85 | 6.76 |
| Interest Debt Per Share | 16095.54 | 25.12 | 25.80 | 32.62 | 50.52 |
| Net Debt to EBITDA | 5.24 | 19.51 | 40.01 | -28.21 | 19.16 |
| Profitability Margins | |||||
| Gross Profit Margin | 27.49% | 45.26% | 46.59% | 27.77% | 38.63% |
| EBIT Margin | 11.36% | 0.88% | -6.62% | -12.08% | 5.57% |
| EBITDA Margin | 15.24% | 12.12% | 6.51% | -5.38% | 15.28% |
| Operating Profit Margin | -0.34% | 0.88% | -4.78% | -18.99% | 9.49% |
| Pretax Profit Margin | 6.34% | -17.55% | -22.65% | -25.80% | -4.43% |
| Net Profit Margin | 6.34% | -17.55% | -22.65% | -19.11% | -4.43% |
| Continuous Operations Profit Margin | 6.34% | -17.55% | -22.65% | -25.80% | -4.43% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 74.10% | 100.00% |
| EBT Per EBIT | -1872.22% | -1998.76% | 473.57% | 135.84% | -46.66% |
| Return on Assets (ROA) | 4.92% | -5.32% | -6.25% | -10.01% | -1.12% |
| Return on Equity (ROE) | 66.87% | 110.24% | -2101.62% | -184.80% | -11.37% |
| Return on Capital Employed (ROCE) | -0.40% | 0.37% | -1.71% | -11.21% | 2.60% |
| Return on Invested Capital (ROIC) | -0.36% | 0.37% | -1.71% | -11.21% | 2.60% |
| Return on Tangible Assets | 4.92% | -5.71% | -6.70% | -10.66% | -1.16% |
| Earnings Yield | 93861.41% | -111.02% | -102.04% | -116.46% | -15.11% |
| Efficiency Ratios | |||||
| Receivables Turnover | 6.13 | 2.93 | 3.21 | 3.49 | 2.48 |
| Payables Turnover | 5.52 | 2.72 | 3.68 | 7.88 | 4.37 |
| Inventory Turnover | 28468.98 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 1484.71 | 0.51 | 0.46 | 0.73 | 0.33 |
| Asset Turnover | 0.78 | 0.30 | 0.28 | 0.52 | 0.25 |
| Working Capital Turnover Ratio | 140.08 | 4.20 | 2.76 | 3.73 | 2.12 |
| Cash Conversion Cycle | -6.62 | -9.80 | 14.48 | 58.33 | 63.66 |
| Days of Sales Outstanding | 59.52 | 124.58 | 113.73 | 104.65 | 147.20 |
| Days of Inventory Outstanding | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 66.15 | 134.38 | 99.25 | 46.32 | 83.55 |
| Operating Cycle | 59.53 | 124.58 | 113.73 | 104.65 | 147.20 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.81 | 1.05 | 1.98 | -2.02 | 2.82 |
| Free Cash Flow Per Share | -1.12 | 0.76 | 1.47 | -2.18 | 2.75 |
| Dividend Paid and CapEx Coverage Ratio | -2.60 | 3.67 | 3.87 | -12.80 | 39.79 |
| Capital Expenditure Coverage Ratio | -2.60 | 3.67 | 3.87 | -12.80 | 39.79 |
| Operating Cash Flow Coverage Ratio | -0.00 | 0.04 | 0.08 | -0.06 | 0.06 |
| Operating Cash Flow to Sales Ratio | -0.00 | 0.11 | 0.22 | -0.10 | 0.18 |
| Free Cash Flow Yield | -87.15% | 48.75% | 72.28% | -65.75% | 61.01% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 1.17 | -0.90 | -0.98 | -0.86 | -6.62 |
| Price-to-Sales (P/S) Ratio | 0.00 | 0.16 | 0.22 | 0.16 | 0.29 |
| Price-to-Book (P/B) Ratio | 0.00 | -0.99 | 20.60 | 1.59 | 0.75 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -1.15 | 2.05 | 1.38 | -1.52 | 1.64 |
| Price-to-Operating Cash Flow Ratio | -1.59 | 1.49 | 1.03 | -1.64 | 1.60 |
| Price-to-Earnings Growth (PEG) Ratio | -0.01 | 0.01 | 0.00 | -0.02 | -2.92 |
| Enterprise Value Multiple | 5.24 | 20.82 | 43.42 | -31.26 | 21.08 |
| Enterprise Value | 42.48M | 46.28M | 48.54M | 60.46M | 85.96M |
| EV to EBITDA | 5.24 | 20.82 | 43.42 | -31.26 | 21.08 |
| EV to Sales | 0.80 | 2.52 | 2.83 | 1.68 | 3.22 |
| EV to Free Cash Flow | -13575.45 | 32.75 | 17.63 | -15.59 | 18.02 |
| EV to Operating Cash Flow | -18795.39 | 23.82 | 13.08 | -16.81 | 17.57 |
| Tangible Book Value Per Share | 1794.57 | -3.79 | -2.11 | -0.25 | 3.58 |
| Shareholders’ Equity Per Share | 1796.79 | -1.57 | 0.10 | 2.09 | 6.00 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 18951.87 | 9.87 | 9.14 | 20.23 | 15.39 |
| Net Income Per Share | 1201.43 | -1.73 | -2.07 | -3.87 | -0.68 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 0.74 | 1.00 |
| Interest Burden | 0.56 | -19.99 | 3.42 | 2.14 | -0.79 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.29 | 0.32 | 0.13 | 0.15 |
| Stock-Based Compensation to Revenue | 0.00 | 0.01 | 0.02 | 0.01 | 0.02 |
| Income Quality | -0.74 | -0.60 | -0.95 | 0.52 | -4.14 |
Currency in USD
